Today: 17 May 2026
Vietnam stocks week ahead: Ho Chi Minh VN-Index faces a settlement test after T+2 glitch

Vietnam stocks week ahead: Ho Chi Minh VN-Index faces a settlement test after T+2 glitch

Ho Chi Minh City, March 1, 2026, 16:19 ICT — The session has ended.

  • HoSE will resume trading on Monday, following a settlement hiccup—some T+2 deliveries were held up late last week due to KRX system maintenance.
  • The VN-Index closed just shy of 1,880 on Friday, lifted by gains in energy and tech stocks; large caps, though, mostly sat out the rally after the Tet holiday.
  • Monday’s manufacturing PMI is first up for traders, followed by a cluster of February macro numbers later in the week.

The Ho Chi Minh Stock Exchange starts the week facing renewed back-office headaches after the securities depository reported a delay in allocating certain securities set for settlement. The holdup followed scheduled IT maintenance performed by the KRX contractor, according to the .

The issue disrupted the T+2 settlement — that’s “trade date plus two business days” — causing a temporary holdup for certain government bonds and equities, brokerage notifications and updates from the depository show. The Investor

The Vietnam Securities Depository and Clearing Corporation managed to finish the delayed settlements later Friday, with brokers telling state media that trading rights came back online around 2:30 p.m.

The VN-Index scraped out a gain on Friday, finishing up just 0.69 point, or 0.04%, at 1,880.33, after tumbling more than 16 points in the early afternoon. Trading value slipped roughly 5%, landing above 30 trillion dong ($1.2 billion). The VN30, tracking HoSE’s largest 30 stocks, dropped 0.39% to 2,061.75.

Oil and gas, tech, and utilities stocks lifted the market, according to VNDIRECT, but insurance and F&B names pulled in the opposite direction. Top index contributors: VIC, BSR, GAS. On the foreign side, net buying reached roughly 190.6 billion dong, with FPT, GMD and MWG attracting the bulk.

Nhi Nguyen at Shinhan Securities said the VN-Index is running up against resistance near 1,900. Friday’s session, she wrote, “looked like a technical shake-out,” with steady cash flow colliding with profit-taking. Nguyen also highlighted fertilizer stocks getting a lift from pricier urea, and noted energy shares did their part to prop up the index.

This week’s data releases kick off with S&P Global’s manufacturing PMI on Monday. Later on, investors will parse February trade, inflation, industrial output, retail sales, and foreign direct investment figures, according to Trading Economics.

Vingroup is looking to bring in as much as $350 million through an international bond offering, giving buyers the right to swap the bonds for shares in Vinpearl, its hospitality unit—a structure the company last tapped in a deal set for late 2025. According to Vingroup, the sale is planned for the second quarter, pending approvals and depending on how markets shape up.

Traders are eyeing whether the post-holiday gains have more room, provided there’s no fresh disruption under the surface. A second settlement delay would be trouble, especially with the index hovering at a critical threshold.

The rally’s breadth has thinned on occasion, with large caps flashing signs of fatigue. If the index stalls near 1,900 again, or if settlement glitches resurface—or weaker February figures come in—banks and consumer names could easily slide back into the red.

Foreign flows remain a key factor. Some stability comes from net buying, especially as locals move to lock in gains, but that support tends to vanish fast once volatility picks up.

Stock Market Today

  • XRP Price Declines Amid Bearish Pressure Near $1.50 Resistance
    May 17, 2026, 5:46 AM EDT. Ripple's XRP is sliding, currently testing support at $1.43. The cryptocurrency faces significant selling pressure near $1.50, which has restricted gains since Monday. This resistance zone is acting as a ceiling, triggering bearish movements and weighing on XRP's short-term outlook.

Latest articles

E-Power Shares Slide as EPOW Ends Day at 66 Cents

E-Power Shares Slide as EPOW Ends Day at 66 Cents

17 May 2026
E-Power Inc. shares closed at $0.66 Friday, down 7.04%, after its annual report showed a 28.59% drop in net revenue to $46.4 million and a widened net loss of $26.66 million, citing “substantial doubt” about its ability to continue as a going concern. The Nasdaq Composite also fell 1.54% Friday, ending a six-week rally. E-Power announced new patents and a $252 million microgrid project earlier in the week.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.05.2026

17 May 2026
LIVEMarkets rolling coverageStarted: May 17, 2026, 4:00 AM EDTUpdated: May 17, 2026, 5:55 AM EDT XRP Price Declines Amid Bearish Pressure Near $1.50 Resistance May 17, 2026, 5:46 AM EDT. Ripple’s XRP is sliding, currently testing support at $1.43. The cryptocurrency faces significant selling pressure near $1.50, which has restricted gains since Monday. This resistance zone is acting as a ceiling, triggering bearish movements and weighing on XRP’s short-term outlook. Why is XRP falling? INFRONEER Holdings' New Stock Grant Trust and Governance Shift Impact Investment Outlook May 17, 2026, 5:45 AM EDT. INFRONEER Holdings Inc. (TSE:5076) reported fiscal 2026 results
Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
STI flirts with 5,000: Yangzijiang and AEM set the pace on SGX in the week ahead
Previous Story

STI flirts with 5,000: Yangzijiang and AEM set the pace on SGX in the week ahead

Dubai Real Estate Forecast After Iran Strikes: What Investors Watch as UAE Markets Reopen
Next Story

Dubai Real Estate Forecast After Iran Strikes: What Investors Watch as UAE Markets Reopen

Go toTop